Skip to main content

Advertisement

SpringerLink
Log in

The management of renal osteodystrophy

  • Practical Pediatric Nephrology
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sherrard DJ, Hercz G, Pei Y, Maloney N, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure — an evolving disorder. Kidney Int 43: 436–442

    Article  PubMed  CAS  Google Scholar 

  2. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, De Bonis E, Darias E, Gonzales-Posada JM, Losada M, Rufino M, Felsenfeld AJ, Rodriguez M (1995) Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 47: 1434–1442

    Article  PubMed  CAS  Google Scholar 

  3. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46: 1160–1166

    Article  PubMed  CAS  Google Scholar 

  4. Sherrard DJ (1986) Renal osteodystrophy. Semin Nephrol 6: 56–67

    PubMed  CAS  Google Scholar 

  5. Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33: 975–982

    Article  PubMed  CAS  Google Scholar 

  6. Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, Segre GV, Fenton S, Sherrard DJ (1993) Aplastic osteodystrophy without aluminum: the role of “suppressed” parathyroid function. Kidney Int 44: 860–866

    Article  PubMed  CAS  Google Scholar 

  7. Pei Y, Hercz G, Greenwood C, Segre GV, Manuel A, Saiphoo C, Fenton S, Sherrard DJ (1995) Fisk factors for renal osteodystrohpy: a multivariant analysis. J Bone Miner Res 10: 149–156

    Article  PubMed  CAS  Google Scholar 

  8. Goodman WG, Coburn JW, Ramirez JA, Slatopolsky E, Salusky IB (1993) Renal osteodystrophy in adult and pediatric patients. In: Favus M (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Raven, New York, pp 304–323

    Google Scholar 

  9. Salusky IB, Coburn JW, Foley J, Nelson P, Fine RN (1986) Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis. J Pediatr 108: 767–770

    Article  PubMed  CAS  Google Scholar 

  10. Salusky IB, Foley J, Nelson P, Goodman WG (1991) Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 324: 527–531

    PubMed  CAS  Google Scholar 

  11. Goodman WG, Salusky IB (1991) Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy. Contrib Nephrol 90: 189–195

    PubMed  CAS  Google Scholar 

  12. Slatopolsky E, Weerts C, Thielan J, Horst RL, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74: 2136–2143

    Article  PubMed  CAS  Google Scholar 

  13. Delmez JA, Dougan CS, Gearing BK, Rothstein M, Windus DW, Rapp N, Slatopolsky E (1987) The effects of intraperitoneal calcitriol on calcium and parathyroid hormone. Kidney Int 31:795–799

    Article  PubMed  CAS  Google Scholar 

  14. Fukagawa M, Kitaoka M, Kaname S, Okazaki R, Matsumoto T, Ogata E, Hoshino M, Inada T, Sekine T, Kurokawa K (1990) Suppression of parathyroid gland hyperplasia by l,25(OH)2D3 pulse therapy. N Engl J Med 315: 421–422

    Google Scholar 

  15. Reichel H, Szabo A, Uhl J, Pesian S, Schmutz A, Schmidt-Gayk H, Ritz E (1993) Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism. Kidney Int 44: 1259–1265

    Article  PubMed  CAS  Google Scholar 

  16. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ (1989) Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321: 274–279

    PubMed  CAS  Google Scholar 

  17. Mazzaferro S, Pasquali M, Ballanti P, Bonucci E, Di Sanza P, Sardella D, Taggi F, Coen G (1994) Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable study. Miner Electrolyte Metab 20: 122–129

    PubMed  CAS  Google Scholar 

  18. Salusky IB, Ramirez JA, Oppenheim WL, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45: 253–258

    Article  PubMed  CAS  Google Scholar 

  19. Lefebvre A, Vernejoul MC de, Gueris J, Goldfarb B, Graulet AM, Morieux C (1989) Optimal correction of acidosis changes progression of dialysis osteodytrophy. Kidney Int 36: 1112–1118

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pediatrics, Radiological Sciences and Medicine, UCLA School of Medicine, Los Angeles, California, USA

    Isidro B. Salusky

  2. UCLA Medical Center, MDCC A2-383, 90024, Los Angeles, CA, USA

    William G. Goodman

Authors
  1. Isidro B. Salusky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William G. Goodman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Pediatric Nephrology received the following question for its Ask the Expert section: ‘What concentration of plasma calcium phosphate and bicarbonate should one hope to achieve, how should plasma calcium be measured, as total calcium or ionised calcium, and how important is it to assess and suppress parathyroid hormone level? What is the value of regular X-ray of the hands and wrists and should urine and calcium phosphate excretion be measured? What are the indications for bone biopsy, and please could you advise concerning the treatment with calcium carbonate or calcium acetate and calcitriol?”

Bearing in mind this is a controversial issue we asked two experts in the field, Dr. Isidro Salusky and Dr. Susan Rigden, to reply.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salusky, I.B., Goodman, W.G. The management of renal osteodystrophy. Pediatr Nephrol 10, 651–653 (1996). https://doi.org/10.1007/s004670050183

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004670050183

Key words

Search

Navigation